Crossject Aktie - ALCJ

Crossject (ALCJ) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

1,91

( -0,93% )

Gebot

1,90

Fragen

1,92

Volumen

285.208

1,892 Tagesbereich 1,94

1,38 52-Wochen-Bereich 2,695

Marktkapitalisierung

103,988M

Handelsende

1,928

Handelsbeginn

1,914

Letzte Trade

663

1.91

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

343.145 €

Ausgegebene Aktien

54.443.789

Dividendenrendite (LTM)

Kurs-Gewinn-Verhältnis

-9,72

Gewinn pro Aktie (EPS)

-0,19

Erlöse (LTM)

2,57M

Nettogewinn (LTM)

-10,37M

Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisi... Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France. Mehr anzeigen

Sektor

Healthcare

Branche

Medical Equipment & Supplies

Website

www.crossject.com

Hauptsitz

Dijon, France

Gegründet

2026

Crossject is listed in the Healthcare sector of the Euronext with ticker ALCJ. The last closing price for Crossject was 1,93 €. Over the last year, Crossject shares have traded in a share price range of 1,38 € to 2,695 €.

Crossject currently has 54.443.789 shares in issue. The market capitalisation of Crossject is 103,99 € million. Crossject has a price to earnings ratio (PE ratio) of -9.72.

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS CROSSJECT Société anonyme au capital social de 5 977 067,50 Euros Siège social : 6, rue Pauline...

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale CROSSJECT met à disposition les...

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million...

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit...

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory DIJON...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.43	-18.3760683761	2.34	2.34	1.892	547804	2.04863597	DE
4	-0.022	-1.13871635611	1.932	2.58	1.84	580632	2.19614147	DE
12	-0.095	-4.73815461347	2.005	2.58	1.84	366785	2.12824172	DE
26	-0.28	-12.7853881279	2.19	2.58	1.8	315852	2.09086316	DE
52	0.07	3.80434782609	1.84	2.695	1.38	286988	2.06134706	DE
156	-1.62	-45.8923512748	3.53	5.96	0.7199	155046	2.25517845	DE
260	-0.85	-30.7971014493	2.76	5.96	0.7199	130727	2.57100332	DE

ALCJ - Frequently Asked Questions (FAQ)

What is the current Crossject share price?

The current share price of Crossject is 1,91 €

How many Crossject shares are in issue?

Crossject has 54.443.789 shares in issue

What is the market cap of Crossject?

The market capitalisation of Crossject is EUR 103,99M

What is the 1 year trading range for Crossject share price?

Crossject has traded in the range of 1,38 € to 2,695 € during the past year

What is the PE ratio of Crossject?

The price to earnings ratio of Crossject is -9,72

What is the cash to sales ratio of Crossject?

The cash to sales ratio of Crossject is 40,88

What is the registered address of Crossject?

The registered address for Crossject is 6 Rue Pauline Kergomard, Dijon, Burgundy, 21000

What is the Crossject website address?

The website address for Crossject is www.crossject.com

Which industry sector does Crossject operate in?

Crossject operates in the Medical Equipment & Supplies sector

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Crossject (ALCJ)

Crossject (ALCJ) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Crossject

ALCJ Neueste Nachrichten

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros

RAPPORT FINANCIER 2025

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

CROSSJECT appoints Lionel Seltz as Chief Financial Officer

CROSSJECT nomme Lionel SELTZ au poste de Directeur Administratif et Financier

CROSSJECT publishes its 2025 financial results and confirms the strengthening of its operational, industrial and financial trajectory

DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS

CROSSJECT met à disposition les réponses aux questions de ses actionnaires préalablement à son Assemblée Générale

CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros

CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million

RAPPORT FINANCIER 2025

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025

CROSSJECT nomme Lionel SELTZ au poste de Directeur Administratif et Financier

ALCJ - Frequently Asked Questions (FAQ)

ALCJ Trades

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich GRATIS und erhalten Sie:

Werbung entfernen